Back
4D Molecular Therapeutics Vs. Builders FirstSource Industry Stock Comparison
Sell
35
FDMT
4D Molecular Therapeutics
Last Price:
25.31
Seasonality Move:
0.41%
Sell
49
BLDR
Builders FirstSource
Last Price:
167.00
Seasonality Move:
6.7%
Sell
35
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.34. The Score for FDMT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Builders FirstSource (BLDR)
is a Sell
Is Builders FirstSource a Buy, Sell or Hold?
- The current Builders FirstSource [BLDR] share price is $167.05. The Score for BLDR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.
BLDR Stock Price Chart
What is Builders FirstSource's stock price today?
-
The Builders FirstSource share price today is $167.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing slight selling pressure.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 44.43 | Sell |
| Chaikin Money Flow: | 193418 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.46 - 26.42) | Sell |
| Bollinger Bands (100): | (20.86 - 30.24) | Sell |
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.4 | Sell |
| Relative Strength Index (14 RSI): | 39.78 | Sell |
| Chaikin Money Flow: | -337678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.74 - 189.2) | Sell |
| Bollinger Bands (100): | (169.66 - 198.36) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.69 | Sell |
| 20-day SMA: | 25.38 | Sell |
| 50-day SMA: | 27.82 | Sell |
| 200-day SMA: | 19.74 | Buy |
| 8-day EMA: | 25.63 | Sell |
| 20-day EMA: | 25.86 | Sell |
| 50-day EMA: | 26.29 | Sell |
| 200-day EMA: | 22.1 | Buy |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 167.64 | Sell |
| 20-day SMA: | 178.45 | Sell |
| 50-day SMA: | 189.88 | Sell |
| 200-day SMA: | 158.52 | Buy |
| 8-day EMA: | 170.04 | Sell |
| 20-day EMA: | 176.53 | Sell |
| 50-day EMA: | 182.8 | Sell |
| 200-day EMA: | 161.7 | Buy |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.
Builders FirstSource Earnings Growth & BLDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.49 per share, a decrease this year of $0.87 per share, and an increase next year of $1.33 per share.
4D Molecular Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Builders FirstSource Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||